By Morgan Stanley names Eli Lilly a top pick, says it has best product outlook in pharma
An exciting new drug for diabetes and weight loss could open up a whole new market for the company, analysts say.
What's your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
